Target intelligence / Profile preview

TP53 target 1 (non-protein coding) (TP53TG1)

Target
TP53TG1
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

TP53 target 1 (TP53TG1) is a long non-coding RNA (lncRNA) identified as a transcriptional target of the tumor suppressor protein p53 (encoded by the TP53 gene) [4]. Unlike p53 itself—a protein with direct tumor suppressor functions—TP53TG1 does not encode a protein but is regulated in response to cellular damage, particularly DNA damage, in a manner dependent on wild-type TP53 activation. It was originally isolated from a colon cancer cell line with regulated p53 expression, and its transcription appears to mark or modulate some downstream p53-regulated responses. While its detailed functional mechanisms remain unclear, TP53TG1 is suggested to be involved in gene regulation related to the p53 signaling pathway [4]. There is no evidence it serves as a current therapeutic target, interacts with drugs, or is used as a biomarker or safety concern in clinical settings.

Other names
H_RG012D21.9LINC00096TP53LC12TP53 target gene 1long intergenic non-protein coding RNA 96NCRNA00096P53TG1P53TG1-DTP53AP1TP53 activated protein 1
02

Biological functions

Regulation of gene expression in response to wild-type TP53 activationPossible involvement in cell cycle regulationResponse to cellular stress and damage
03

Disease associations

Cancer (linked as a downstream target of TP53, a major tumor suppressor) [4]

Beyond the preview

Go deeper on TP53 target 1 (non-protein coding) (TP53TG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TP53 target 1 (non-protein coding) (TP53TG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call